Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms, Plasma Cell 2Multiple Myeloma 2cyclopia sequence 1Tobacco Use Cessation 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Nocturia 1Myelodysplastic Syndromes 1Lymphoma 1Lung Neoplasms 1Leukemia 1Hodgkin Disease 1Health Education 1Head and Neck Neoplasms 1Fatigue 1Dyspnea 1Carcinoma, Non-Small-Cell Lung 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1Advanced Cancers 1

Interventions

Trimetazidine 1Thioctic Acid 1Surveys and Questionnaires 1Paclitaxel 1Cilostazol 1Carnosine 1Acupuncture Therapy 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Peripheral Nervous System Diseases × Surveys and Questionnaires × Clear all
NCT02168894 2016-03-08

SINF: Peripheral Neuropathy in Cancer Survivors

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn

Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡